Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bain Capital
Biotech
Areteia posts ph. 3 asthma win for oral rival to biologic drugs
Three years on from a splashy unveiling, Areteia has reported data that could boost its bid to disrupt a multibillion-dollar asthma market.
Nick Paul Taylor
Sep 16, 2025 9:20am
Apreo Health nets $130M to develop lung scaffold for emphysema
Aug 8, 2025 11:30am
BMS hands 5 autoimmune drugs to Bain-backed spinout
Jul 29, 2025 5:08am
Third Rock-backed Merida unveils with $121M for autoimmune plans
Apr 8, 2025 11:03am
Gene therapy biotech secures $150M for eye disease candidates
Apr 2, 2025 7:30am
Wearable defibrillator maker Kestra Medical plots $150M IPO
Feb 26, 2025 12:00pm
